MILLENNIUM MANAGEMENT LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1273087 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$90,946,528

+$59,726,959 QoQ

Shares Held

153,372

+139.4% QoQ

Ownership

0.361%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Derivatives in UTHR

reported options exposure · as of Mar 31, 2026

CallValue

$42,991,050

CallShares

72,500

PutValue

$46,786,122

PutShares

78,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $1,131,904,343 across 44 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,649,955	$195,041,180
2	SUPN	Supernus Pharmaceuticals, Inc.	3,315,973	$171,402,644
3	NBIX	Neurocrine Biosciences Inc	1,247,447	$164,338,667
4	INDV	Indivior Pharmaceuticals, Inc.	4,595,535	$140,071,906
5	UTHR	UNITED THERAPEUTICS Corp This page	153,372	$90,946,528
6	TEVA	Teva Pharmaceutical Industries Ltd	1,893,845	$57,042,611
7	PRGO	PERRIGO Co plc	4,279,731	$45,964,310
8	ANIP	Ani Pharmaceuticals Inc	592,013	$45,525,799

All Filings in UTHR

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$90,946,528	153,372	+111.5%	Shares	Sole	2026-05-15
2026-03-31	$42,991,050	72,500	-8.1%	Call	Sole	2026-05-15
2026-03-31	$46,786,122	78,900	+23.1%	Put	Sole	2026-05-15
2025-12-31	$31,219,569	64,073	+429.5%	Shares	Sole	2026-02-17
2025-09-30	$5,072,441	12,100	-95.3%	Put	Sole	2025-11-14
2025-09-30	$108,398,064	258,577	+235.5%	Shares	Sole	2025-11-14
2025-06-30	$22,144,340	77,064	+1809.9%	Shares	Sole	2025-08-14
2025-03-31	$1,243,869	4,035	-85.6%	Shares	Sole	2025-05-15
2024-12-31	$9,900,337	28,059	+750.3%	Shares	Sole	2025-02-14
2024-12-31	$1,164,372	3,300	-68.3%	Put	Sole	2025-02-14
2024-09-30	$3,726,840	10,400	+52.9%	Put	Sole	2024-11-14
2024-09-30	$2,436,780	6,800	-24.8%	Call	Sole	2024-11-14
2024-09-30	$3,241,634	9,046	+131.9%	Shares	Sole	2024-11-14
2024-06-30	$1,242,345	3,900	-96.2%	Call	Sole	2024-08-14
2024-06-30	$32,820,525	103,031	+711.3%	Shares	Sole	2024-08-14
2024-06-30	$4,045,585	12,700	-70.9%	Put	Sole	2024-08-14
2024-03-31	$10,033,480	43,677	-63.4%	Shares	Sole	2024-05-15
2023-12-31	$26,212,867	119,209	-51.8%	Shares	Sole	2024-02-14
2023-09-30	$55,886,562	247,428	+88.5%	Shares	Sole	2023-11-14
2023-06-30	$28,972,775	131,247	-49.1%	Shares	Sole	2023-08-14
2023-03-31	$57,746,070	257,841	-49.3%	Shares	Sole	2023-05-15
2022-12-31	$141,345,638	508,273	-12.6%	Shares	Sole	2023-02-14
2022-09-30	$121,798,439	581,710	+20.8%	Shares	Sole	2022-11-14
2022-06-30	$113,436,624	481,398	-17.5%	Shares	Sole	2022-08-15
2022-03-31	$104,739,199	583,798	+2235.2%	Shares	Sole	2022-05-16
2022-03-31	$4,485,250	25,000	-93.9%	Call	Sole	2022-05-16
2021-12-31	$87,974,811	407,140	+11.1%	Shares	Sole	2022-02-14
2021-09-30	$67,624,943	366,372	+510.6%	Shares	Sole	2021-11-15
2021-09-30	$11,074,800	60,000	-89.2%	Call	Sole	2021-11-15
2021-06-30	$99,238,667	553,139	+1006.3%	Shares	Sole	2021-08-16
2021-03-31	$8,363,500	50,000	-87.5%	Call	Sole	2021-05-17
2021-03-31	$67,050,514	400,852	+701.7%	Shares	Sole	2021-05-17
2021-03-31	$8,363,500	50,000	-91.8%	Put	Sole	2021-05-17
2020-12-31	$92,317,615	608,193	+26.9%	Shares	Sole	2021-02-16
2020-09-30	$48,403,846	479,246	+5.7%	Shares	Sole	2020-11-16
2020-06-30	$54,857,891	453,371	+2166.9%	Shares	Sole	2020-08-14
2020-03-31	$1,896,600	20,000	-97.6%	Call	Sole	2020-05-14
2020-03-31	$80,562,447	849,546	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.